Supply Chain Council of European Union | Scceu.org
Distribution

FDA, companies add 3 heartburn meds to recall amid cancer concerns

FDA, companies add 3 heartburn meds to recall amid cancer concerns

A sample of NDMA, an impurity that has been linked to an increased risk for colorectal and uterine cancers, was found in samples of ranitidine, a drug used to treat and prevent heartburn by reducing stomach acid. It’s sold under the brand name Zantac. Valisure, a small pharmacy that checks the composition of drugs, and is responsible for the world-wide recall of the heartburn drug Zantac. (Stan Godlewski /The Washington Post via Getty Images)

Related posts

Area businesses alarmed over unemployment fund debate

scceu

The 2020 Wine-Searcher Retailer Awards

scceu

To enhance reliability, Texas regulators will consider standardizing distribution system interconnections

scceu